Turning Innovation into Predictable Cash Flow

How CFOs use public funding programmes as a strategic financial tool

Companies spending €5 million a year on R&D can secure €1.05 million to €1.4 million in annual cash inflow through the research tax credit, plus a one-off retrospective benefit of up to €5.6 million. Most never claim it. Not because they are ineligible. Because three structural flaws block it: funding treated as a project rather than a process, finance and R&D working in silos, and liquidity effects left out of financial planning.

That is a governance deficit, and it shows up directly in cash flow, margins and audit assurance. This white paper is for CFOs and finance leaders who treat funding as a financial instrument, not an application. It explains how a group-wide process changes the profit and loss account, cash flow and equity ratio.